Accéder au contenu
Merck
  • A novel method for the determination of chemical purity and assay of menaquinone-7. Comparison with the methods from the official USP monograph.

A novel method for the determination of chemical purity and assay of menaquinone-7. Comparison with the methods from the official USP monograph.

Journal of pharmaceutical and biomedical analysis (2016-12-27)
Łukasz Jedynak, Maria Jedynak, Magdalena Kossykowska, Joanna Zagrodzka
RÉSUMÉ

An HPLC method with UV detection and separation with the use of a C30 reversed phase analytical column for the determination of chemical purity and assay of menaquinone-7 (MK7) in one chromatographic run was developed. The method is superior to the methods published in the USP Monograph in terms of selectivity, sensitivity and accuracy, as well as time, solvent and sample consumption. The developed methodology was applied to MK7 samples of active pharmaceutical ingredient (API) purity, MK7 samples of lower quality and crude MK7 samples before purification. The comparison of the results revealed that the use of USP methodology could lead to serious overestimation (up to a few percent) of both purity and MK7 assay in menaquinone-7 samples.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Supelco
Menaquinone -7, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
LDN-57444, ≥98% (HPLC)